Sai Life Sciences Reports Q2 FY27 Results and Senior Management Additions
Sai Life Sciences Ltd · Change in Management · 06 Nov 2026, 4:35 am
Sai Life Sciences Reports Q2 FY27 Results and Senior Management Additions Sai Life Sciences approved its Q2 FY27 results, reporting consolidated revenue from operations of ₹6,585.85m, up 22.5% YoY (vs ₹5,374.70m in Q2 FY26) and 18.8% QoQ. Consolidated net profit reached ₹983.17m, rising 17.3% YoY and 34.2% QoQ, with diluted EPS at ₹4.58. The board approved key senior management appointments effective 5th Nov'26: Sidhartha Das (SVP & Head HR), Vijay Kumar Suthari (VP - Head Quality & Regulatory Affairs), and Sriram Gopalakrishnan (SVP - Corporate Communications). Additionally, 108,005 equity shares were allotted under ESOP schemes.
Original exchange filing (PDF)
More announcements from Sai Life Sciences Ltd
- Upgradation in the Credit Rating by India Rating & Research Pvt. Ltd. · 14 Nov 2026
- Transcripts of Earnings call organized on 06th November 2026 · 12 Nov 2026
- Monitoring Agency Report for the Quarter ended 30th September 2026 · 12 Nov 2026
- Audio Recording of Earnings call for Q-2 FY 2026-27 · 06 Nov 2026
- Investor Presentation on Q-2 FY 2026-27 Financial Results · 06 Nov 2026
- Press Release on Unaudited Financial Results for the Second Quarter and Half Year Ended 30th September 2026. · 06 Nov 2026
- Allotment of 1,08,005 Equity having Face Value of Rs.1/- against the options exercised in accordance with the Companies ESOP Plans · 06 Nov 2026
- Sai Life Sciences Limited has informed the Exchange regarding Allotment of 108005 Shares. · 06 Nov 2026
